diff --git a/.nojekyll b/.nojekyll
index 21f9c37..893ac74 100644
--- a/.nojekyll
+++ b/.nojekyll
@@ -1 +1 @@
-c89f4655
\ No newline at end of file
+16a1d323
\ No newline at end of file
diff --git a/SCE-Roundtables.docx b/SCE-Roundtables.docx
index 9ec4fb5..d2ec731 100644
Binary files a/SCE-Roundtables.docx and b/SCE-Roundtables.docx differ
diff --git a/SCE-Roundtables.pdf b/SCE-Roundtables.pdf
index e648e7e..fffad3f 100644
Binary files a/SCE-Roundtables.pdf and b/SCE-Roundtables.pdf differ
diff --git a/contributors.html b/contributors.html
index 9a8bc4c..37aab7e 100644
--- a/contributors.html
+++ b/contributors.html
@@ -222,9 +222,8 @@
Table of contents
@@ -273,8 +272,16 @@
- Participants
+
+ Organising committee
+
+- Phil Bowsher, R/Pharma executive; Posit
+- James Black, R/Pharma executive; Roche
+- Harvey Lieberman, R/Pharma executive; Novartis
+
+
+
+ Participants
Ordered alphabetically by company;
- Rose (Abbot Labs)
@@ -304,36 +311,6 @@ Susheel (Vertex)
- Derek (WL Gore)
-
-
- Organising committee
-
-- Phil Bowsher, R/Pharma executive; Posit
-- James Black, R/Pharma executive; Roche
-- Harvey Lieberman, R/Pharma executive; Novartis
-
-
-
- Advisory board
-
-- Cassie Milmont; Amgen
-- Lee Min; Amgen
-- Michael Blanks, R/Pharma executive; Beigene
-- Ning Leng, R/Pharma organizing committee; Genentech
-- Doug Kehlkoff, R Validation Hub Lead; Genentech
-- Michael Rimler; GSK
-- Andy Nicholls; GSK
-- Volha Tryputsen, R/Pharma organizing committee; J&J
-- Sumesh Kalappurakal; J&J
-- Mark Bynens; J&J
-- Harvey Lieberman, R/Pharma executive; Novartis
-- Shannon Pileggi; The Prostate Cancer Clinical Trials Consortium (PCCTC)
-- Mike Smith; Pfizer
-- Max Kuhn; Posit
-- Rich Ioannone; Posit
-- Paulo Bargo, R/Pharma executive
-- James Black, R/Pharma executive; Roche
-
diff --git a/search.json b/search.json
index 169d5b9..2dc4f5e 100644
--- a/search.json
+++ b/search.json
@@ -169,32 +169,22 @@
"8 Contributors"
]
},
- {
- "objectID": "contributors.html#participants",
- "href": "contributors.html#participants",
- "title": "8 Contributors",
- "section": "8.2 Participants",
- "text": "8.2 Participants\nOrdered alphabetically by company;\n\nRose (Abbot Labs)\nMike (Astellas)\nLimin (Atmos)\nDaniel (Astrazeneca)\nKevin (BI)\nMathias (BI)\nEric (Biogen)\nMary (BMS)\nNicole (Denali)\nMike Thomas (Flatiron Health)\nDaniel (Formycin)\nSatish Murphy (Johnson & Johnson)\nNick (Johnson & Johnson)\nJan (Moffat Cancer Centre)\nHarvey (Novartis)\nLi (Onc)\nJames Kim (Pfizer)\nMike (Pfizer)\nMichael Meyer (Posit)\nDoug (Roche)\nJeeva (Roche)\nJames Black (Roche)\nAndrew (Sanofi)\nAbigail (Tempest)\nSusheel (Vertex)\nDerek (WL Gore)",
- "crumbs": [
- "8 Contributors"
- ]
- },
{
"objectID": "contributors.html#organising-committee",
"href": "contributors.html#organising-committee",
"title": "8 Contributors",
- "section": "8.3 Organising committee",
- "text": "8.3 Organising committee\n\nPhil Bowsher, R/Pharma executive; Posit\nJames Black, R/Pharma executive; Roche\nHarvey Lieberman, R/Pharma executive; Novartis",
+ "section": "8.2 Organising committee",
+ "text": "8.2 Organising committee\n\nPhil Bowsher, R/Pharma executive; Posit\nJames Black, R/Pharma executive; Roche\nHarvey Lieberman, R/Pharma executive; Novartis",
"crumbs": [
"8 Contributors"
]
},
{
- "objectID": "contributors.html#advisory-board",
- "href": "contributors.html#advisory-board",
+ "objectID": "contributors.html#participants",
+ "href": "contributors.html#participants",
"title": "8 Contributors",
- "section": "8.4 Advisory board",
- "text": "8.4 Advisory board\n\nCassie Milmont; Amgen\nLee Min; Amgen\nMichael Blanks, R/Pharma executive; Beigene\nNing Leng, R/Pharma organizing committee; Genentech\nDoug Kehlkoff, R Validation Hub Lead; Genentech\nMichael Rimler; GSK\nAndy Nicholls; GSK\nVolha Tryputsen, R/Pharma organizing committee; J&J\nSumesh Kalappurakal; J&J\nMark Bynens; J&J\nHarvey Lieberman, R/Pharma executive; Novartis\nShannon Pileggi; The Prostate Cancer Clinical Trials Consortium (PCCTC)\nMike Smith; Pfizer\nMax Kuhn; Posit\nRich Ioannone; Posit\nPaulo Bargo, R/Pharma executive\nJames Black, R/Pharma executive; Roche",
+ "section": "8.3 Participants",
+ "text": "8.3 Participants\nOrdered alphabetically by company;\n\nRose (Abbot Labs)\nMike (Astellas)\nLimin (Atmos)\nDaniel (Astrazeneca)\nKevin (BI)\nMathias (BI)\nEric (Biogen)\nMary (BMS)\nNicole (Denali)\nMike Thomas (Flatiron Health)\nDaniel (Formycin)\nSatish Murphy (Johnson & Johnson)\nNick (Johnson & Johnson)\nJan (Moffat Cancer Centre)\nHarvey (Novartis)\nLi (Onc)\nJames Kim (Pfizer)\nMike (Pfizer)\nMichael Meyer (Posit)\nDoug (Roche)\nJeeva (Roche)\nJames Black (Roche)\nAndrew (Sanofi)\nAbigail (Tempest)\nSusheel (Vertex)\nDerek (WL Gore)",
"crumbs": [
"8 Contributors"
]